Company
United StatesFox Chase Cancer Center IRB, Philadelphia, PA – FDA Inspections
Inspection records and compliance data for Fox Chase Cancer Center IRB in Philadelphia, Pennsylvania. 2 FDA inspections on record, last inspected September 10, 2025.
Company Profile
This profile covers Fox Chase Cancer Center IRB based in Philadelphia, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 14, 2019. Last inspected September 10, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 10, 2025 | NAI | Biologics, Human Drugs, Medical Devices & Rad Health · Bioresearch Monitoring | 1283950 |
| February 14, 2019 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1081268 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Mary Washington Hospital IRB
UCSF Human Research Protection Program
Ballad Health IRB
Medical University South Carolina IRB
East Tennessee State University/Veterans Affairs IRB
University of Texas Health Science Center at Houston IRB
Covenant Health System IRB
BayCare Health Systems IRB
Marquette General Health System IRB
Allendale IRB
Company Information
Name
Fox Chase Cancer Center IRB
FEI Number
2518761
Address
333 Cottman Ave, Philadelphia, Pennsylvania 19111, United States
Country
United States
ID: eba459da-2b39-4528-8f2a-4a8e056f0fe7